Close Window

Digital Look Email A Friend

AstraZeneca calls off two phase III trials into hyperkalaemia treatment

Published by Iain Gilbert on 1st December 2023

(Sharecast News) - Drugmaker AstraZeneca has called off two phase III trials on its hyperkalaemia treatment after a series of logistical challenges.

URL: http://www.digitallook.com/dl/news/story/33944380/...

Email this article to your friends
NOTE: These email addresses will be used to email the information on your behalf and will not be collected by Digital Look for any marketing purposes.